Clinical Trial Update: Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating adoptive T lymphocyte therapy to treat chronic norovirus infection in immunocompromised patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disorders
• Norovirus Infection

Drugs mentioned

• Adoptive T Lymphocyte Therapy (adoptive T cell therapy)

Snippet

Sponsor: Children's National Research Institute | Conditions: Viral Infection, Hematopoietic Stem Cell Transplantation (HSCT) | Phase 1 | Status: RECRUITING